Financials China Reform Health Management and Services Group Co., Ltd.

Equities

000503

CNE000000255

Business Support Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
9 CNY -1.32% Intraday chart for China Reform Health Management and Services Group Co., Ltd. +11.25% -31.71%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 14,273 15,388 7,514 15,332 9,209 12,971
Enterprise Value (EV) 1 13,534 14,558 6,612 14,618 8,675 11,786
P/E ratio -76 x 882 x -31 x -86.6 x -109 x -150 x
Yield - - - - - -
Capitalization / Revenue 149 x 118 x 36.2 x 60.7 x 29.6 x 39.3 x
EV / Revenue 142 x 112 x 31.9 x 57.9 x 27.9 x 35.7 x
EV / EBITDA -77.8 x -87.1 x -52.8 x -102 x -85.7 x -152 x
EV / FCF 126 x -105 x 41.6 x -380 x -57.2 x -108 x
FCF Yield 0.8% -0.95% 2.4% -0.26% -1.75% -0.93%
Price to Book 11.8 x 12.6 x 7.82 x 19.5 x 12.9 x 8.8 x
Nbr of stocks (in thousands) 898,822 898,822 898,822 907,215 906,413 984,176
Reference price 2 15.88 17.12 8.360 16.90 10.16 13.18
Announcement Date 4/26/19 4/24/20 4/23/21 4/29/22 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 95.48 129.9 207.4 252.5 311.1 330.1
EBITDA 1 -174.1 -167.1 -125.3 -143.2 -101.2 -77.39
EBIT 1 -180.8 -173.1 -129.4 -146.8 -104 -106.6
Operating Margin -189.32% -133.24% -62.39% -58.12% -33.44% -32.28%
Earnings before Tax (EBT) 1 -182.5 16 -242.8 -176.9 -83.19 -78.41
Net income 1 -187.8 17.43 -242.6 -175.8 -84.47 -79.79
Net margin -196.65% 13.41% -116.99% -69.63% -27.15% -24.17%
EPS 2 -0.2089 0.0194 -0.2699 -0.1952 -0.0931 -0.0876
Free Cash Flow 1 107.7 -138.8 159 -38.48 -151.8 -109.6
FCF margin 112.77% -106.86% 76.67% -15.24% -48.79% -33.19%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/26/19 4/24/20 4/23/21 4/29/22 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 740 830 902 714 534 1,185
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 108 -139 159 -38.5 -152 -110
ROE (net income / shareholders' equity) -14.5% 1.27% -19% -20.2% -11.3% -7.53%
ROA (Net income/ Total Assets) -8.28% -8.37% -5.43% -7.37% -5.66% -4.36%
Assets 1 2,268 -208.3 4,466 2,385 1,492 1,831
Book Value Per Share 2 1.350 1.360 1.070 0.8700 0.7800 1.500
Cash Flow per Share 2 0.7500 0.7900 0.5500 0.3900 0.1900 0.9800
Capex 1 37.5 32.5 17.7 23.1 37.7 52.1
Capex / Sales 39.31% 25.05% 8.54% 9.16% 12.11% 15.77%
Announcement Date 4/26/19 4/24/20 4/23/21 4/29/22 4/26/23 4/26/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000503 Stock
  4. Financials China Reform Health Management and Services Group Co., Ltd.